Form 4: HCI Group COO Receives New Restricted Stock Grant
Insider Transaction Report
HCI Group's Chief Operating Officer, Karin Sue Coleman, was granted 1,251 shares of restricted common stock, vesting over three years.
Summary
- Karin Sue Coleman, Chief Operating Officer and Director of HCI Group, Inc. (HCI), reported an acquisition of securities.
- On December 19, 2025, Ms. Coleman was granted 1,251 shares of common stock as a restricted stock grant.
- These 1,251 restricted shares will vest in three equal installments of 417 shares on October 23, 2026, October 23, 2027, and October 23, 2028.
- The grant was made pursuant to the company's 2012 Omnibus Incentive Plan and a restricted stock agreement dated December 19, 2025.
- Following this transaction, Ms. Coleman directly beneficially owns 24,325.14 shares of common stock, 34,000 previously granted restricted shares (scheduled to vest on May 22, 2026), and the newly granted 1,251 restricted shares.
Sentiment
Score: 7
Explanation: The grant of restricted stock to a key executive is a positive for internal alignment and retention, though it's a routine compensation event with limited direct market impact.
Positives
- The grant of 1,251 restricted shares aligns management interests with shareholder value, incentivizing long-term performance.
- The multi-year vesting schedule promotes executive retention and continued commitment to the company's success.
Risks
- The vesting of the restricted shares is contingent upon continued employment by the Issuer, meaning forfeiture if employment terminates prior to the vesting dates.
Future Outlook
The multi-year vesting schedule for the restricted stock grants indicates a long-term commitment from the Chief Operating Officer to the company's performance and continued employment, suggesting stability in executive leadership.
Industry Context
The grant of restricted stock to a key executive is a common practice in publicly traded companies, particularly within the insurance and financial services sectors, to incentivize long-term performance and retain talent, aligning executive interests with shareholder value.
Comparison to Industry Standards
- The use of restricted stock grants as a component of executive compensation is a widely adopted practice across various industries, including insurance, comparable to incentive plans at companies like Progressive (PGR) or Allstate (ALL).
- This mechanism aims to foster long-term alignment between executive performance and shareholder returns, a standard in corporate governance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation | Grant of restricted stock under the company's 2012 Omnibus Incentive Plan to the Chief Operating Officer, aligning executive incentives with long-term company performance. | 12/19/2025 | Enhances executive retention and aligns management interests with shareholder value through performance-based equity, reinforcing the company's compensation strategy. |
Stakeholder Impact
- Shareholders: Potential for long-term value creation through incentivized management; minor dilution from new share grants is a standard aspect of equity compensation.
- Employees: Reinforces the company's commitment to executive compensation and retention strategies, potentially signaling stability in leadership.
Next Steps
- Vesting of 417 restricted shares on October 23, 2026.
- Vesting of 417 restricted shares on October 23, 2027.
- Vesting of 417 restricted shares on October 23, 2028.
- Vesting of 34,000 previously granted restricted shares on May 22, 2026, contingent on continued employment.
Key Dates
| Date | Description |
|---|---|
| 02/26/2021 | Effective date of a previous restricted stock grant of 34,000 shares. |
| 12/19/2025 | Date of the current restricted stock grant of 1,251 shares to Karin Sue Coleman. |
| 12/23/2025 | Signature date of the Form 4 filing by Andrew L. Graham as Attorney-in-fact for Karin Coleman. |
| 05/22/2026 | Scheduled vesting date for the previously granted 34,000 restricted shares, contingent on continued employment. |
| 10/23/2026 | Scheduled vesting date for 417 shares of the 1,251 restricted stock grant. |
| 10/23/2027 | Scheduled vesting date for 417 shares of the 1,251 restricted stock grant. |
| 10/23/2028 | Scheduled vesting date for 417 shares of the 1,251 restricted stock grant. |
Recommendation
holdThis Form 4 reports a routine restricted stock grant to a key executive, which is a standard compensation practice aimed at retention and alignment. It does not present new information that would fundamentally alter the investment thesis for HCI Group, hence a 'hold' recommendation is appropriate as it confirms ongoing executive incentives without indicating significant operational or financial shifts.
Keywords
HCI Group, Insider Transaction, Restricted Stock, Karin Coleman, Executive Compensation, Equity Grant, COO, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.